Sensor-augmented pump therapy for A1C reduction (STAR 3) study: Results from the 6-month continuation phase

R. M. Bergenstal, W. V. Tamborlane, A. Ahmann, J. B. Buse, G. Dailey, S. N. Davis, C. Joyce, B. A. Perkins, J. B. Welsh, S. M. Willi, M. A. Wood

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)S112-S113
JournalDiabetes Technology and Therapeutics
Volume15
Issue numberSUPPL.1
DOIs
StatePublished - Jun 1 2013

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this

Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Perkins, B. A., Welsh, J. B., Willi, S. M., & Wood, M. A. (2013). Sensor-augmented pump therapy for A1C reduction (STAR 3) study: Results from the 6-month continuation phase. Diabetes Technology and Therapeutics, 15(SUPPL.1), S112-S113. https://doi.org/10.1089/dia.2013.1512